These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16312338)

  • 1. The versatile monobactam family: new agents addressing specific needs in infectious disease.
    Bonner DP; Koster WH
    J Chemother; 1989 Jul; 1(4 Suppl):133-4. PubMed ID: 16312338
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitivity to beta-lactams and aminoglycosides of clinically important pathogens isolated from children in Poland.
    Dzierzanowska D; Kamińska W
    J Chemother; 1989 Jul; 1(4 Suppl):366-7. PubMed ID: 16312442
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative antibacterial activity of the new oral monobactam tigemonam (SQ 30836) against urinary isolates.
    Cocuzza G; Raimondi A
    J Chemother; 1989 Jul; 1(4 Suppl):126-8. PubMed ID: 16312335
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro interactions between cefotetan and aminoglycosides on Klebsiella, Enterobacter and Serratia species.
    Debbia E; Stefani S; Nicoletti G; Schito GC
    Chemioterapia; 1987 Jun; 6(2 Suppl):94-5. PubMed ID: 3509543
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridone-conjugated monobactam antibiotics with gram-negative activity.
    Brown MF; Mitton-Fry MJ; Arcari JT; Barham R; Casavant J; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Lall MS; Lemmon MM; Li C; Lin J; McCurdy SP; McElroy E; McPherson C; Marr ES; Mueller JP; Mullins L; Nikitenko AA; Noe MC; Penzien J; Plummer MS; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Tomaras A; Young JA; Zaniewski RP
    J Med Chem; 2013 Jul; 56(13):5541-52. PubMed ID: 23755848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part V. Other beta-lactam antimicrobials.
    Gibbs WJ; Cooper TW; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Jan; 100(1):23-5. PubMed ID: 17378498
    [No Abstract]   [Full Text] [Related]  

  • 7. 3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis.
    Hemati S; Ghafourian S; Sadeghfard N; Mahdavi Z; Maleki A; Sayehmiri F; Sayehmiri K; Bogdanovic L; Taherikalani M
    Recent Pat Antiinfect Drug Discov; 2017; 12(1):3-7. PubMed ID: 28137227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The versatile monobactam family: manipulation of intrinsic activity and in vivo efficacy via N-1 activating group modification.
    Koster WH; Bonner DP; Zahler R
    J Chemother; 1989 Jul; 1(4 Suppl):116-8. PubMed ID: 16312331
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic susceptibility of the Klebsiella-Aerobacter-Serratia group.
    Fekety FR; Partain PJ
    Univ Mich Med Cent J; 1969; 35(3):155-7. PubMed ID: 5384682
    [No Abstract]   [Full Text] [Related]  

  • 10. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of antibacterial activity of the MB-1 siderophore-monobactam conjugate using an efflux pump inhibitor.
    Tomaras AP; Crandon JL; McPherson CJ; Nicolau DP
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2439-42. PubMed ID: 25605364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of isepamicin against Pseudomomas aeruginosa and Enterobacter cloacae strains resistant to amikacin: a preliminary report.
    Giamarellou H; Pephanis A; Florentin I; Petrikkos G; Avlamis A; Grammatikou M
    J Chemother; 1989 Jul; 1(4 Suppl):399-400. PubMed ID: 16312458
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in sensitivity to PA-1806 among iron transport mutants of Pseudomonas aeruginosa compared to Escherichia coli.
    Schwan WR; Barker L; Brody LL
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3237-8. PubMed ID: 11184229
    [No Abstract]   [Full Text] [Related]  

  • 16. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metallo-beta-lactamases producing Pseudomonas aeruginosa in Algeria].
    Aggoune-Khinache N; Bensersa D; Henniche FZ; Daoudi M; Abdouni MA; Chabani A; Tiouit D; Naim M
    Med Mal Infect; 2009 Jun; 39(6):413-4. PubMed ID: 19111417
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa.
    Scheetz MH; Esterly JS; Malczynski M; Postelnick M; Qi C
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):465-7. PubMed ID: 19394788
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.
    Maciá MD; Mena A; Borrell N; Pérez JL; Oliver A
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4531-2. PubMed ID: 17893154
    [No Abstract]   [Full Text] [Related]  

  • 20. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.